MedPath

BR6001-1

Generic Name
BR6001-1

A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

Phase 1
Completed
Conditions
Gastric or Duodenal Ulcer
Interventions
First Posted Date
2023-12-11
Last Posted Date
2024-02-01
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
Target Recruit Count
30
Registration Number
NCT06165237
Locations
🇰🇷

ChungBuk National University Hospital, Chungbuk, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath